Empfield James R.
EVP, Drug Discovery at XENE
- Sold, on record
- $3.8M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Aug 12, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XENEXenon Pharmaceuticals Inc.EVP, Drug Discovery
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale XENEUnusualMar 7, 2022 2022
Sold 51,168 shares at $30.63 ($1.6M)
Empfield James R., EVP, Drug Discovery
Sold 83.7% of holdings ($1.9M position)10,000 shares leftFirst sale on recordFiling
- 2 Form 4 sale XENEUnusualAug 12, 2022 +158 days
Sold 57,743 shares at $38.31 ($2.2M)
Empfield James R., EVP, Drug Discovery
Sold 85.2% of holdings ($2.6M position)10,000 shares leftFiling
Every transaction
Loading transactions…